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Abstract 
The study examined the effects of a licensed live Salmonella Typhimurium vaccine, administered to 
sows and gilts on three commercial pig units experiencing clinical salmonellosis associated with 
S. Typhimurium or its monophasic variant. After vaccination, clinical salmonellosis resolved and 
shedding of S. Typhimurium declined markedly and persistently on all breeding or breeding-
finishing units, during the one- to two-year monitoring period. On two finishing units supplied in 
part by one of the vaccinated herds, pigs from the vaccinated herd were less likely to shed 
Salmonella than those from non-vaccinating herds, and Salmonella counts in faeces were also lower 
from the vaccine-linked animals. Non-Typhimurium Salmonella serovars were isolated typically in 
fewer than 10% of samples, and showed no clear temporal changes in frequency. Vaccination of 
dams alone with S. Typhimurium was associated with reduced shedding of closely-related serovars 
among all age groups in this commercial setting. 
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Abbreviations 
APHA  Animal and Plant Health Agency 
BPW  Buffered peptone water 
CMI  Cell-mediated immunity 
mST  Monophasic Salmonella Typhimurium 
ST  Salmonella Typhimurium  
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Introduction 
Salmonella in commercial pig production is a well-documented issue [1–3], with the principal 
concern in developed countries being one of public health risk from subclinical carriage on farms 
leading to contamination of food [4]. The control of Salmonella carriage and shedding by pigs, 
particularly in the finishing stages leading up to slaughter, can be challenging. The organism is 
robust in the environment, and infection cycles with currently-prevalent broad host range serovars 
such as Salmonella Typhimurium (ST) and its monophasic variant (mST) are frequently 
asymptomatic in livestock. Infection is readily acquired via oral or respiratory exposure, invasion of 
intestinal tissue and associated lymph nodes occurs, and shedding in faeces may be prolonged 
and/or reactivated by stress [5]. 
 
Strategies for control of Salmonella in pig herds in most countries typically attempt to reduce rather 
than eliminate infection or shedding, although aggressive policies involving segregation, 
depopulation, intensive cleaning and monitoring are practised successfully in some territories [6]. 
Controls to reduce Salmonella centre on biosecurity, reducing opportunities for new strains to enter 
the premises, and reducing infection pressure and transmission opportunities within a unit by means 
of hygiene, pest control, segregation and group management [3,7,8]. Animals’ resistance to 
Salmonella infection can also be enhanced, in some cases by altering feed and feeding practices [9], 
but also by vaccination. 
 
Over many years, candidate vaccines for Salmonella in pigs have developed, from killed bacterins 
injected parenterally to elicit a humoral response, to live or adjuvanted vaccines that additionally 
stimulate cell-mediated immunity (CMI). Humoral immunity alone has a limited effect on 
Salmonella [10], because for much of the infection cycle the organism is intracellular, shielded from 
antibody action. CMI, characterised by a Th1 lymphokine profile associated with activation of 
macrophages and cytotoxic lymphocytes, appears to be a critical part of effective anti-Salmonella 
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immunity [11,12]. Live Salmonella vaccines, presented to mucosal surfaces, theoretically offer the 
best combination of antigen presentation and co-stimulatory signals to elicit CMI and mucosal 
immunity [13]. Live attenuated Salmonella strains offer the additional advantage for farmed species 
that inoculation can often be performed by non-parenteral routes (principally in drinking water or 
by aerosol), without the need for handling and injection of individual animals. 
 
Whilst many experimental challenge studies have been reported involving candidate Salmonella 
vaccines [13,14], relatively few have involved field studies, and still fewer have tackled field 
situations with broad host range serovars, such as are often seen in modern pig production. Among 
these, Arguello et al. [15] used an inactivated ST DT104 vaccine injected into grower pigs and 
demonstrated significant reductions in ST shedding after vaccination and in colonisation of 
mesenteric lymph nodes and caecum at slaughter, although Salmonella of other serogroups was not 
significantly reduced. Schwartz et al. [16] reported that a live Salmonella Choleraesuis (C1 
serogroup) commercial vaccine, given orally to day-old piglets in an integrated production system 
with predominantly B-serogroup endemic strains, was associated with modest but significant 
decreases in individual-level seroprevalence and mesenteric lymph node colonisation at slaughter. 
Finally, a further trial used a different commercial S. Choleraesuis vaccine (cya/crp mutant) given in 
drinking water at three and 16 weeks of age to pigs on a unit with diverse endemic Salmonella 
serovars [17]. Compared with controls, there were significantly fewer Salmonella-positive ileo-
caecal lymph nodes among vaccinates at slaughter (0.7% vs 7.2%). 
 
‘Salmoporc’ is a live ST commercial vaccine strain, attenuated by mutagenesis to make it 
auxotrophic for adenine and histidine synthesis (Springer et al., 2001). Trials have reported safety 
and some degree of efficacy when it has been used in experimental ST-challenge studies. These 
have involved vaccinating dams and/or pre-weaned piglets [18], or vaccinating weaners 
subsequently challenged by oral dosing [19,20] or by seeder pigs [21]. The rationale to vaccinate 
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dams is to reduce shedding around farrowing and to provide passive immunity to offspring [22]. 
 
Sometimes, the stimulus to adopt or trial a Salmonella vaccination programme is the appearance or 
persistence of a clinical salmonellosis problem on a unit. In the present observational studies, 
investigation of such problems on three breeding units associated with ST or its monophasic variant 
prompted trials of maternal vaccination using ‘Salmoporc’, with follow-up of the breeding and 
rearing animals by faeces and environmental sampling for up to two years after the initial (pre-
vaccination) visit. Thus, the immediate aim of controlling clinical salmonellosis provided an 
opportunity for a more long-term assessment of the effects of vaccination on the various units upon 
subclinical shedding of Salmonella. This latter effect is potentially highly relevant to protection of 
consumers from Salmonella in the food chain. 
 
 
Materials and Methods 
Farms 
Five UK pig farms were studied. The three breeding units (farms A1, B and C) were all 
experiencing clinical problems (diarrhoea, septicaemia, ill-thrift and increased mortality) in weaned 
pigs, associated with Salmonella infections. 
 
Farm A1 was an outdoor breeding unit, recently stocked with around 800 gilts. Replacement gilts 
had been found to be heavily shedding ST and mST on arrival at around four weeks of age. The 
herd was moved to a different site between visits two and three. Farms A2 and A3 were outdoor 
grower/finisher units (part of a larger 20-site organisation) which received weaner pigs at around 
five weeks of age from Farm A1 and from other breeding farms that were not practising sow 
vaccination. One newly-established site was sampled on all occasions, whilst three sites of longer 
occupation were sampled once (two sites) or twice (one site). 
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Farms B and C were large (400-sow) indoor breeder-finisher units. ST was present on Farm C and 
mST had been identified on Farm B, and problems with rodent control were evident on both these 
units. 
 
Vaccination 
Salmoporc STM (IDT Biologika, Dessau-Rosslau, Germany) was administered to pre-partum sows 
and gilts as two (1 ml) subcutaneous injections, three weeks apart and two to three weeks before 
farrowing for the initial course, with a single booster dose two to three weeks before each 
subsequent farrowing. 
 
Sampling and Salmonella detection 
Multiple sampling visits were conducted, the first before the initial vaccinations and then on two to 
four additional occasions over the following year (Farms A2, A3, B and C) or two years (Farm A1). 
Sixty individual faeces samples were collected per epidemiological group (dry sows, lactating sows, 
weaners, etc.) where possible given the number of animals present, providing a 95 % probability of 
detection given a 5 % prevalence and 100 % sensitivity of detection. Faeces were taken into sterile 
stool sample tubes using an integral spoon. In addition, pooled pen faeces samples (one or two 
pools per pen, including pre-weaned piglet faeces in farrowing accommodation) were taken, using a 
sterile gauze swab held with a clean disposable glove for each sample on indoor units or by making 
a pool from pinches of 10 droppings on outdoor units.  
In addition, wildlife and environmental samples were collected. Solid and semi-solid material was 
collected using sterile gauze swabs, whilst surfaces were wiped with gauze swabs that had been pre-
autoclaved in buffered peptone water (BPW). Materials and areas sampled included: rodent faeces 
and (occasionally) carcases; wild bird faeces; flies; cleaned and empty pens and farrowing crates; 
pooled water and mud in paddocks, wallows and tracks; water troughs; feed barrows and dust from 
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feed handling areas; piglet transporters; handling facilities; manure heaps and associated runoff 
fluid; vehicles, trailers, loader buckets and scrapers. Details are given in the supplementary table. 
 
Samples (n=7201) were transported to the testing laboratory on the day of collection. Material was 
cultured for Salmonella either immediately upon arrival (pooled faeces and swabs in BPW) or after 
overnight storage at 4 °C (individual faeces samples), using a modification of the ISO 6579:2002 
(Annex D) method, as described previously [23]. Briefly, all pooled faeces samples (approximately 
25g) and swabs were pre-enriched in 225 ml BPW for 18 h followed by sequential inoculation onto 
Modified Semi-Solid Rappaport-Vassiliadis and Rambach agar. Sub-samples (2 g) of individual pig 
faeces samples and samples of aseptically dissected rodent carcass intestines plus liver and spleen, 
were pre-enriched in 20 ml BPW and cultured as above. The residue of the individual pig faeces 
samples were stored unprocessed at 4 °C. Among individual faeces samples that proved 
Salmonella-positive, a representative subset of the stored material was subjected to a semi-
quantitative enumeration procedure by creating a decimal dilution series in BPW immediately 
before pre-enrichment, as described elsewhere [24]. A representative selection (all isolates from 
pooled samples and any individual sample that was cultured semi-quantitatively) of Salmonella 
isolates were fully sero- and phage-typed at the APHA Salmonella reference laboratory using 
standard methodology [25]. 
 
Statistical analysis 
Statistical analyses were performed in Stata 12 (StataCorp, 2011. Stata Statistical Software: Release 
12. College Station, TX: StataCorp LP). A mixed-effects logistic regression model was used to 
examine associations on farms A2 and A3 between finisher type (i.e. linked with vaccinated sows or 
not linked) and the odds of Salmonella-positive samples. Sample categories of environmental, 
individual faeces and pooled faeces were included a priori. Sampling visit number was included as 
a random effect, to account for the non-independence of samples collected at the same farm visit. 
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For an overall analysis of the effect of vaccination on all of the farms, a mixed-effects logistic 
regression model was again used, to examine the association between time from the start of 
vaccination (represented by visit number, with the first visit being before the introduction of 
vaccination) and the odds of a sample being Salmonella-positive, the hypothesis being that 
vaccination would progressively reduce the odds of a sample being positive over time. The a priori 
variables were sample (environmental, breeder, weaner, grower or finisher), faeces sample type 
(individual or pooled), and the number of days elapsed since the first visit to that farm. Farm 
identification was added as a random effect, with farms A1, A2 and A3 treated as a single farm in 
this respect. An interaction term was added to allow for different effects of the vaccine over visits 
on the different farms. The explanatory variable was the visit number, which was compared against 
two outcomes: Salmonella-positive or ST/mST-positive. 
 
Results 
On all farms clinical problems in weaners attributable to Salmonella, plus the need to use high 
doses of antibiotics at weaning, was reported by farmers and their veterinary advisers to be 
substantially improved after vaccination was introduced. 
 
Farm A1 
Five visits were made, between October 2010 and October 2012, with 422 to 605 samples collected 
per visit from the breeding herd. Weaners were not retained on the premises and consequently were 
not sampled. Bacteriological findings from faeces samples are summarised in Figure 1 and Table 1.  
The initial visit demonstrated a heavy prevalence of ST/mST shedding (45.3% of individual 
samples), with mST the more common. At the second visit, following the start of the vaccination 
programme, the reduction in prevalence of ST/mST-positive individual faeces samples was marked 
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among ST/mST serovars. This comparatively low level of ST/mST shedding was evident at all 
subsequent visits, with mST always the more common variant. The reduction in the proportion of 
pooled samples positive for ST/mST was also marked, although more progressive over time than 
for the individual samples. Isolates of ST/mST from environmental and wildlife (mostly bird) 
samples similarly decreased progressively and markedly, from 62% of samples initially, to 11% and 
1% on the last two visits. Rodent activity was subjectively assessed as low and localised, and the 
few rat faeces samples obtained were Salmonella-negative. 
 
Non-ST/mST isolates from pigs were confined to serovars Panama and Derby, initially isolated only 
from pooled samples and at later visits from both individual and pooled samples. Environmental 
samples on occasion also yielded serovars Bovismorbificans, Newport and Reading.  The most 
frequent isolations of non-ST/mST serovars in pooled faeces (17%) and environmental (14%) 
samples were made at the initial visit, which may have reflected largely transient shedding by the 
newly-arrived stock. On any visit thereafter, the proportion of samples positive for non-ST/mST 
Salmonella was between zero and 10%  for any sample category (individual, pooled or 
environmental), with a trend of modest increase over time (Table 1). At the final visit, Salmonella 
Panama was the commonest serovar (including ST/mST) from all sample types. 
 
Farms A2 and A3 
Four visits were made, between November 2011 and December 2012, starting a year after the 
vaccination programme had commenced on Farm A1. Between 188 and 457 samples were taken on 
each occasion, sampling pigs from around six weeks of age and above. Findings from faeces 
samples are summarised in Figure 1 and Table 1. Shedding of ST/mST was not uniformly less 
frequent among linked pigs compared with unlinked pigs over the four visits. However, on visits 
one and two the semi-quantitative Salmonella counts of individual faeces samples among pigs 
linked to farm A1 (median and maximum log ranges 0-1 and 1-2 cfu.g-1, respectively) were lower 
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than those from unlinked pigs (corresponding ranges 2-3 and 5-6 cfu.g-1). Heavy recent rainfall may 
have affected findings on the third and final visits, when the proportion of ST/mST-positive 
environmental samples increased to 67% and 44% respectively, having previously been around 
10%. Semi-quantitative counts on some individual faeces samples (median and maximum log 
ranges 0-1 and  ≤ 2-3 on both occasions for both linked and unlinked pigs) indicated that shedding 
on these occasions, although more prevalent, was generally of low intensity.  
 
None of the 1092 individual faeces samples from linked or unlinked pigs were positive for non-
ST/mST serovars. Nine of 16 sets of pooled or environmental samples were similarly negative. Of 
the other seven sets, between 2.1% and 8.3% of samples were positive for either Salmonella Derby 
or Salmonella Apapa. 
 
Farm B 
Three visits were made, between June 2012 and April 2013, and with 566-677 samples collected 
each time. By the time of the final visit, all finishing stock had been born to vaccinated dams. The 
unit staff reported a marked decline in clinical salmonellosis following the start of vaccination. 
Bacteriological findings are summarised in Figure 2 and Table 1. ST was not isolated. Monophasic 
ST was detected infrequently from individual faeces samples in the breeding herd. For this serovar 
the proportion of positive pooled samples was initially moderate (30%) in this group, but this fell to 
below 1% on the two visits made after the start of the vaccination programme for breeding animals. 
Among weaners and growers, the prevalence of Salmonella isolations from individual samples fell 
rapidly after vaccination was introduced, from initially high values (>60%), to around or below 
10% by the third visit. The proportion of positive pooled samples also fell, but more slowly and 
progressively. The initial prevalence of ST/mST-positive individual samples among the finisher pigs 
(18.5%) was more modest than for the younger groups, but this too had reduced (to 1.7%) by the 
third visit, with a parallel reduction in pooled sample isolations. Although the frequency of mST 
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isolation from weaners’ individual faeces samples reduced over time, Salmonella counts remained 
similar at each visit, with median and maximum log ranges of 1-2 and 3-5, respectively. However, 
among older growing stock initial maximum counts of 2-3 log units reduced to 0-1 at subsequent 
visits. 
A reduction among environmental sample isolations of ST/mST was also seen, from around 35 % of 
samples on the first two visits to 6 % on the last. Evidence of mouse activity was commonly seen 
(especially among growers) at the first visit, and attempts to improve control met with limited 
success. Few rodent faeces samples were obtained, as mice were living within the insulation layers 
of pig housing, but mST was commonly isolated from mouse faeces samples. 
 
Non-ST/mST isolations were uncommon (less than 2 % of samples per visit in any sampling 
category) and absent among weaners and growers. Most isolates were from the breeding herd and 
finishers, with serovars Anatum, Mbandaka and Stourbridge identified. 
 
Farm C 
Three visits were completed, between July 2011 and August 2012, with 396 to 422 samples being 
collected on each occasion from the breeding herd, weaners, and multi-age grower-finisher houses. 
The primary aim was to monitor the distribution of Salmonella across the farm by representatively 
sampling the animal groups present, and on Farm C the groups were particularly numerous and the 
pens diverse. Therefore, within funding constraints, a strategy was adopted of taking many pooled 
faeces samples but no individual ones. There was a marked decline in clinical salmonellosis after 
the start of vaccination, as reported by staff. Bacteriological findings are summarised in Figure 3 
and Table 1. Monophasic ST was not isolated. The proportion of ST-positive pools reduced in all 
animal categories from initial pre-vaccination values, and in all cases the reduction was substantial 
by the third and final visit. Pooled faecal samples from finishing animals showed the least rapid 
reductions. A parallel reduction in environmental isolations of ST was also seen: 33% of samples 
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initially, with 7.7% at the last visit. Rat control improved substantially over the study period but 
mice remained poorly controlled. In one finishing house ST in pooled samples did not decline as 
rapidly as in other houses, and mouse infestation here was noted to be especially severe. 
 
Non-Typhimurium isolates were most commonly Salmonella Derby among breeding animals, and 
Salmonella Senftenberg among finishers and environmental samples. Serovars Havana, Cerro, 
Putten and Tennessee were also isolated from these last two sample categories. The frequency of 
isolation of non-Typhimurium Salmonella within animal categories varied from zero to 10.6% on 
any occasion but, unlike ST, there was no pattern of reducing isolations over time. 
 
Statistical analysis 
Findings from the logistic regression analyses are summarised in Table 2. Examining the 
relationship between maternal vaccination and sample Salmonella status among young-stock on 
farms A2 and A3, there was an increased odds ratio (OR = 1.39) of a sample being positive among 
pigs not linked to vaccinated sows, although the difference did not achieve the conventional 
significance limit (P = 0.076). A model that excluded data from the last two visits (when heavy 
rainfall may have affected the spread of Salmonella on these outdoor units) did show significantly 
increased odds (P < 0.001) of Salmonella-positive samples among unlinked pigs, for all serovars 
(OR = 4.21) and for ST/mST alone (OR = 3.85). The analysis of the frequency of Salmonella  
isolations over time on all the farms revealed significant reductions in the odds of isolation at all 
visits after the initial (pre-vaccination) visit, both for S. Typhimurium (or its monophasic variant) 
and for all serovars. 
 
Discussion 
The resolution of clinical salmonellosis on affected units following vaccination is consistent with 
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other field research findings of same-serovar clinical protection by modified live Salmonella 
vaccines [26,27]. Furthermore, substantial and significant reductions in the proportion of ST/mST-
positive samples were seen on all breeding and breeding-finishing units following the start of the 
vaccination programmes. 
 
On the finishing units (farms A2 and A3, receiving stock both from the vaccinating Farm A1 and 
non-vaccinating units elsewhere) the pattern of Salmonella isolation was more mixed than 
elsewhere. This may well have been influenced by heavy rainfall before the last two visits, with an 
increased prevalence but lower intensity of shedding (i.e. reduced Salmonella counts) being 
consistent with increased environmental challenge. Analysis for these units that excludes data from 
this latter period suggests an underlying effect of vaccination that is more marked than that shown 
by the complete dataset. Furthermore, the intensity of shedding on these two units appeared to be 
substantially reduced among offspring of vaccinated dams, compared with the other finishers. 
Similarly, a reduction in maximum Salmonella counts was observed among growers and finishers 
on Farm B after vaccination commenced. 
 
These are several reasons to be careful about interpreting the present findings. These data arise from 
observational field studies, uncontrolled and non-randomised, where vaccination was prompted by 
the investigation of an existing Salmonella problem. Vaccination was undertaken in the context of 
other efforts to improve Salmonella control, variously by pest proofing and population control of 
rodents and wild birds. Therefore, some of the improvements in Salmonella shedding and 
contamination may potentially have been a consequence of these alternative measures. Furthermore, 
in some cases investigations and interventions may have been prompted because clinical 
salmonellosis and shedding were at a natural (and transient) peak. Therefore some improvement 
might have occurred owing to natural cycles of immunity within herds. There may also have been 
interactions, whereby (for example) vaccination may not have been effective if threshold levels of 
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rodent control were not achieved. Finally, a proportion of the reduction seen for Farm A1 may have 
resulted from movement of the herd to new accommodation after the second visit. 
 
Nonetheless, it is reasonable to postulate that the vaccination programmes at least contributed to the 
observed improvements in Salmonella control, and in many respects details in the data support this. 
Immediate and sustained improvements in ST and/or mST shedding were seen in all breeding 
groups after implementation of vaccination, even when rodent control was not markedly improved 
in some cases. The time lag seen with reductions in shedding by growing pigs on the breeder-
finisher units is also consistent with enhanced passive immunity and reduced carriage of infection 
by weaners, eventually propagating into growers and finishers. This would be the expected 
mechanism of maternal vaccination, if effective. The dramatic improvements among weaners and 
growers on Farm B are noteworthy as they suggest that, prior to vaccination, immunologically naïve 
weaners from a breeding herd with little active Salmonella infection were readily infected by mST 
either carried over from farrowing accommodation or within the nursery. 
 
A slower reduction in Salmonella-positive pooled samples is consistent with a greater sensitivity for 
detection of shedding within a group for this sample type, compared with individual samples, as 
previously noted [28]. Thus, pooled samples appear not to be sensitive monitors of short-term 
responses to an intervention such as vaccination, but they are a sensitive monitor of residual 
Salmonella excretion, and indeed of an environmental reservoir for challenge such as in the 
breeding/farrowing environment in Farm B.  
 
Growers and finishers exposed to fresh environmental Salmonella challenge, after passive immunity 
from vaccinated dams had waned would not be expected to show enhanced resistance to 
colonisation and shedding. In the situations where challenge to older growing stock was likely to be 
higher (farms A2 and A3 after heavy rain, Farm B house with heavy mouse infestation), there did 
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indeed appear to be rather limited protection afforded to stock from vaccinated dams. Studies using 
Salmoporc and a ST challenge dose [18], or an autologous mST vaccine plus natural exposure [29], 
have reported that best protection against shedding and organ colonisation in growing pigs was seen 
when maternal plus juvenile Salmonella vaccination was performed in sequence. Nonetheless, 
where challenge levels after weaning can be kept low (by interventions that may include reduced 
carriage by passively-protected weaners), the present study suggests that maternal vaccination alone 
may provide protection that keeps infection pressure low throughout rearing. Compared with 
protocols involving juvenile vaccination, such a strategy can reduce administration costs and avoids 
the risk of vaccine strain being present in the lymph nodes of slaughtered pigs. 
 
It is interesting in this context that the frequency of isolations of ST/mST from environmental 
sources tended to decline in parallel with that from the pooled faeces sample types. This suggests 
that environmental Salmonella levels on pig units largely reflect recent shedding by animals, rather 
than representing a primary driver for pig infection. A high environmental Salmonella level may be 
primary when there are specific external factors causing it, but even then the consequences for pig 
infection may vary according to whether the factor(s) result in spreading Salmonella (for example 
wet weather on an outdoor unit) or in focussing, intensifying and prolonging the challenge, such as 
may be seen with rodent infestations [30]. On farms A2 and A3, wet weather was followed by an 
increased frequency of shedding of Salmonella, but at comparatively low concentrations, indicating 
that this may have been transient cycling of environmental organisms without true colonisation of 
the gut. 
 
It appeared that there was little or no control of non-mST/ST salmonellas following vaccination. An 
initial decline in other serovar isolations on Farm A1 probably reflects transient strains from the 
large numbers of brought-in stock, and in all cases either no pattern over time is evident, or there 
appears to have been a modest increase in alternative serovar isolations as mST/ST declined. The 
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significant reduction in isolation of ‘all serovars’ over time probably reflects the numerical 
dominance of mST/ST isolations in the data. This pattern is consistent with the limitations of cross-
serovar protection against colonisation and shedding seen in experimental studies [31–34]. Few of 
the non-mST/ST serovars isolated were commonly isolated from UK wildlife in the same period 
[35], thus indicating that feed and/or incoming stock were the likely sources. Many of these 
alternative serovars are likely to have been transient, shedding frequency was generally low, and 
none of them carry a similarly high pathogenic importance for humans as ST or mST.  
 
With the current circumstances, in Europe and elsewhere, of herd Salmonella infections typically 
being subclinical and associated with broad-host-range serovars [1,36], the use of vaccination is 
increasingly focussed on the reduction of Salmonella risk at slaughter and onward into the human 
food chain, without interfering with monitoring schemes. If vaccination is applied at an early stage 
in production (and particularly ante-partum), the risk of adverse effects on monitoring for 
Salmonella at slaughter by serology or culture is reduced. With modern biotechnologies and 
immunological insights, Salmonella vaccines show considerable promise for making a substantial 
contribution to the safety of food from the pig sector [37]. However, longitudinal field studies (such 
as the present one) examining natural infections are comparatively uncommon amongst reports of 
Salmonella vaccination trials in pigs, despite such situations being the target of most commercial 
applications of vaccination. 
 
The current study provides promising evidence of control of salmonellosis and sustained reductions 
in ST and mST shedding among pigs up to slaughter age, following vaccination of dams with a live 
attenuated ST vaccine. Observed alterations in shedding differed between pig units, and other 
factors may have contributed to the effects observed. Controlled interventional field trials would be 
needed to quantify the respective contributions of these various factors. 
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Table 1: Isolations of Salmonella from individual and naturally-pooled faeces plus environmental samples on the five study farms 
Farm, date of visit 
Percentage of Salmonella-positive samples: Typhimuriuma, non-Typhimurium (total number of samples) 
Breeding herd   Weaners   ‘Unlinked’ animals (Farms A2 & A3)b, or Growers (B)   ‘Linked’ animals (Farms A2 & A3)
b, Finishers (B), Growers/Finishers (C)  Environmental/wildlife samples Individual Pooled  Individual Pooled  Individual Pooled  Individual Pooled  
A1              
Oct ‘10 45.3,   0.0 (375) 73.9, 17.4   (23)           61.9, 14.3   (63) 
Mar ‘11   7.4,   0.4 (282) 25.0,   0.0   (56)           28.6,   0.0   (84) 
Oct ‘11   2.0,   0.3 (344)   7.7,   1.9   (52)             5.1,   4.0, (198) 
Apr ’12   5.2,   2.6 (346)   8.9,   7.1   (56)           11.3,   5.9, (203) 
Oct ‘12   1.3,   4.9 (305)   2.9,   3.6 (137)             0.8,   9.8, (133) 
A2 & A3              
Nov ‘11         7.8   0.0 (180) 42.9,   7.1   (14)    2.5,   0.0 (120)   8.8,   2.9   (34)  12.8,   2.1   (47) 
May ‘12         2.2   0.0 (186) 19.4,   2.8   (36)    0 9,   0.0 (116)   8.3,   0.0   (24)  10.0,   5.0   (20) 
Jul ‘12         4.6   0.0 (216) 38.9,   8.3   (36)  11.1,   0.0 (144) 50.0,   0.0   (24)  67.6,   0.0   (37) 
Dec ‘12       28.1   0.0   (32) 50.0,   0.0     (6)  13.9,   0.0   (96) 38.5,   0.0   (18)  44.4,   2.8   (36) 
B              
Jun ‘12   3.7,   0.0 (163) 30.2,   2.6 (116)  61.7,   0.0   (60) 96.7,   0.0   (30)  66.7,   0.0   (24) 84.6,   0.0   (26)  18.5,   0.0   (81) 60.0,   3.1   (65)  33.3,   0.0     (3) 
Dec ‘12   0.0,   0.7 (150)   0.8,   0.0 (123)  18.3,   0.0   (60) 58.3,   0.0   (48)    5.0,   0.0   (60) 55.6,   0.0   (18)    5.6,   0.0   (90) 66.7,   1.2   (81)  34.5,   0.0   (29) 
Apr ‘13   0.6,   0.6 (179)   0.9,   1.8 (112)  11.7,   0.0   (60) 29.8,   0.0   (57)    5.0,   0.0   (60) 33.3,   0.0   (18)    1.7,   0.0   (60) 15.9,   1.6   (63)    5.9,   1.5   (68) 
C              
Jul ‘11    8.5,   0.7 (142)c   22.2,   0.0   (99)      19.4,   7.5   (93)  33.3,   4.5   (66) 
Jan ‘12    0.0,   5.3 (131)c     0.9,   0.0 (108)      17.0,   2.3   (88)    0.0,   2.9   (69) 
Aug ‘12    0.8,   0.8 (122)c     0.0,   0.0 (122)        4.4, 10.6 (113)    7.7,   7.7   (65) 
a Including monophasic variants. b Growers and finishers either born to (‘linked’) or not born to (‘unlinked’) vaccinated dams. c Includes pre-weaned piglets. Underlined data is from before the start of the vaccination programmes  
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Table 2: Results of logistic regression analyses on Salmonella status of faecal and environmental swab samples, from farms accommodating Salmonella-vaccinated dams and their offspring 
 No. of days after pre-vaccination sampling 
Salmonella-positive  ST / mST-positivea 
 Odds ratio p-value  Odds ratio p-value 
Farms A2/A3       
Linked - Ref. -  Ref. - 
Unlinked - 1.39 0.076  1.25 0.232 
All farms       
Visit 1 0 Ref. -  Ref. - 
Visit 2 161-182 0.033 <0.001  0.01416  <0.001 
Visit 3 308-402 0.002 <0.001  0.00029 <0.001 
Visit 4 541-569 0.002 <0.001  0.00008 <0.001 
Visit 5 640 0.002   0.001  0.00008 <0.001 
Visit 6 729-792 0.001   0.001  0.00001 <0.001 
Results from farms A2/A3 compare Salmonella status of samples from pigs born to vaccinated dams (‘linked’) with those from premises where vaccination was not performed (‘unlinked’); n = 1422. Results from ‘all farms’ compare Salmonella status over time, compared with an initial pre-vaccination baseline; n = 6416. Not all farms had more than three visits and ‘visit number’ in the analysis indicates the time band within which the visit occurred; in some cases this does not correlate strictly with the cumulative number of visits to a farm. 
a Salmonella Typhimurium / monophasic S. Typhimurium. 
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 Bars show isolations from individual faeces samples, whilst circles show isolations from naturally-pooled faeces samples. ‘Linked’ animals were born to Salmonella-vaccinated dams, whilst ‘unlinked’ ones were not. Error bars show 95% confidence intervals for the individual sample prevalence data. Salmonella vaccination of sows on Farm A commenced between the first and second sampling occasions. 
Figure 1: Isolations of S. Typhimurium and monophasic S. Typhimurium from Farm A1 (black) and farms A2 and A3 (patterned) over a two-year period. 
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 Bars show isolations from individual faeces samples, whilst circles show isolations from naturally-pooled faeces samples. Error bars show 95% confidence intervals for the individual sample prevalence data. Salmonella vaccination of sows commenced between the first and second sampling occasions. 
Figure 2: Isolations of monophasic S. Typhimurium from Farm B 
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 Isolations from naturally-pooled faeces samples. Error bars show 95% confidence intervals. Salmonella vaccination of sows commenced between the first and second sampling occasions. 
Figure 3: Isolations of S. Typhimurium from Farm C 
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